PubMed ID: 8583381The influence of the suppository bases on the in-vivo release of 99mTc-labelled isoconazole nitrate was investigated. The single-dose vaginal suppository formulations for local treatment of vaginitis were prepared by a fusion method using polyethylene glycols, Witepsol H15, Novata BD and Cremao. Prepared vaginal suppositories containing solid-labelled substance were applied to the vagina of rabbits and at 0, 2 and 24 h after administration, the amounts of radioactivity in the vagina were detected by the SPECT Gamma Camera and the release rates of the drug were calculated. The percent released was found to be in the following order; polyethylene glycol (PEG) 6000 > PEG 4000 > Witepsol > PEG 1500 > Novata BD >...
The objective of this study was to develop vaginal suppository containing lactobacillus. Four kinds ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...
PubMed ID: 8583381The influence of the suppository bases on the in-vivo release of 99mTc-labelled is...
WOS: A1995RY38900004PubMed ID: 8583381The influence of the suppository bases on the in-vivo release ...
PubMed ID: 8583380The influence of the suppository base on the in-vitro release of isoconazole nitra...
PubMed ID: 14577974Vaginal suppository formulations of metronidazole were prepared using six differe...
WOS: A1995RY38900003PubMed ID: 8583380The influence of the suppository base on the in-vitro release ...
In this study, ornidazole and polyethylene glycol-6000 (PEG), a suppository base, were labeled with ...
WOS: 000241320400008PubMed ID: 17069425The aim of this study was to investigate and compare the diss...
The key purpose of this study was to prepare and evaluate of in situ gelling Miconazole nitrate liqu...
The aim of this study was to compare the bone uptake of alendronate sodium (ALD) from vaginal suppos...
WOS: 000245983300003PubMed ID: 17454033The aim of our study was to formulate a stable multiple emuls...
Metronidazole containing granules were formulated with different quantities of Carbopol ETD 2020. Th...
WOS: 000344741300007PubMed ID: 24096820The main objective of this study was to investigate the relea...
The objective of this study was to develop vaginal suppository containing lactobacillus. Four kinds ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...
PubMed ID: 8583381The influence of the suppository bases on the in-vivo release of 99mTc-labelled is...
WOS: A1995RY38900004PubMed ID: 8583381The influence of the suppository bases on the in-vivo release ...
PubMed ID: 8583380The influence of the suppository base on the in-vitro release of isoconazole nitra...
PubMed ID: 14577974Vaginal suppository formulations of metronidazole were prepared using six differe...
WOS: A1995RY38900003PubMed ID: 8583380The influence of the suppository base on the in-vitro release ...
In this study, ornidazole and polyethylene glycol-6000 (PEG), a suppository base, were labeled with ...
WOS: 000241320400008PubMed ID: 17069425The aim of this study was to investigate and compare the diss...
The key purpose of this study was to prepare and evaluate of in situ gelling Miconazole nitrate liqu...
The aim of this study was to compare the bone uptake of alendronate sodium (ALD) from vaginal suppos...
WOS: 000245983300003PubMed ID: 17454033The aim of our study was to formulate a stable multiple emuls...
Metronidazole containing granules were formulated with different quantities of Carbopol ETD 2020. Th...
WOS: 000344741300007PubMed ID: 24096820The main objective of this study was to investigate the relea...
The objective of this study was to develop vaginal suppository containing lactobacillus. Four kinds ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...
In this study our objective was to develop suitable vaginal formulations of ornidazole, to evaluate ...